Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report.

Kazuya TakedaToshiyuki SumiYuta NagahisaKeigo MatsuuraMotoki SekikawaHiroki WatanabeYuichi YamadaHirofumi Chiba

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2022)

Clinicians should be aware of Pneumocystis pneumonia as a cause of refractory exacerbation of bronchial asthma during use of interleukin-5 inhibitors.

Keyphrases

chronic obstructive pulmonary disease
lung function
allergic rhinitis
respiratory failure
palliative care
early onset
community acquired pneumonia
cystic fibrosis
drug induced
acute respiratory distress syndrome